Indacaterol, Mometasone

BEMRIST BREEZHALER 125 microgramos/127,5 microgramos POLVO PARA INHALACION (CAPSULA DURA)

0,173 mg + 0,160 mg polvo para inhalación (cápsula dura)SpainMarketedAuthorised 16 Dec 2020

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

Bemrist BreezhalerEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Indacaterol, Mometasone

BEMRIST BREEZHALER 125 microgramos/127,5 microgramos POLVO PARA INHALACION (CAPSULA DURA)

0,173 mg + 0,160 mg polvo para inhalación (cápsula dura)SpainMarketedAuthorised 16 Dec 2020

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

Bemrist BreezhalerEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Romania · 125micrograme/62.5micrograme · pulb. de inhal. capsule · Novartis Europharma Limited

Atectura®Breezhaler®Serbia · 125mcg+127.5mcg · prašak za inhalaciju, tvrda kapsula · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)

Atectura®Breezhaler®Serbia · 125mcg+260mcg · prašak za inhalaciju, tvrda kapsula · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)

Atectura®Breezhaler®Serbia · 125mcg+127.5mcg · prašak za inhalaciju, tvrda kapsula · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)

Atectura 150/160MCG Inhalation Powder,Hard CapsuleSaudi Arabia · Siegfried Barbera S.L

AtecturaBrazil · Novartis Biociencias S.A

Atectura BreezhalerCanada · 150 MCG + 160 MCG · Capsule · Novartis Pharmaceuticals Canada INC

Atectura BreezhalerCanada · 150 MCG + 320 MCG · Capsule · Novartis Pharmaceuticals Canada INC

Atectura BreezhalerCanada · 150 MCG + 80 MCG · Capsule · Novartis Pharmaceuticals Canada INC

Atectura BreezhalerEuropean Union · Novartis Europharm Limited

Atectura BreezhalerItaly · Polvere per inalazione, capsula rigida · Novartis Europharm Limited

AtecturaSaudi Arabia · Siegfried Barbera S.L

Atectura Breezhaler Inhalation Powder, Hard Capsule 150 MCG /160 MCGSingapore · 150 mcg + 160 mcg · powder, metered · Novartis (Singapore) Pte LTD

Atectura Breezhaler Inhalation Powder, Hard Capsule 150 MCG /320 MCGSingapore · 150 mcg + 320 mcg · powder, metered · Novartis (Singapore) Pte LTD

Atectura Breezhaler Inhalation Powder, Hard Capsule 150 MCG /80 MCGSingapore · 150 mcg + 80 mcg · powder, metered · Novartis (Singapore) Pte LTD

Packs

Pack	Code	Status
BEMRIST BREEZHALER 125 microgramos/127,5 microgramos POLVO PARA INHALACION (CAPSULA DURA), 30 cápsulas+ 1 inhalador	729878

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Indacaterol, Mometasone
Strength: 0,173 mg + 0,160 mg
Dosage form: polvo para inhalación (cápsula dura)
Route: vía inhalatoria
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 16 Dec 2020
Registration: 1201441006
Marketing authorisation holder: Novartis Europharm Limited
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica
EU number: EU/1/20/1441

Indacaterol + Mometasone · 0,173 mg + 0,320 mg · polvo para inhalación (cápsula dura)

Spain

ATECTURA BREEZHALER 125 microgramos/62,5 microgramos POLVO PARA INHALACION (CAPSULA DURA)Indacaterol + Mometasone · 0,173 mg + 0,080 mg · polvo para inhalación (cápsula dura)Spain

BEMRIST BREEZHALER 125 microgramos/260 microgramos POLVO PARA INHALACION (CAPSULA DURA)Indacaterol + Mometasone · 0,173 mg + 0,320 mg · polvo para inhalación (cápsula dura)Spain

BEMRIST BREEZHALER 125 microgramos/62,5 microgramos POLVO PARA INHALACION (CAPSULA DURA)Indacaterol + Mometasone · 0,173 mg + 0,080 mg · polvo para inhalación (cápsula dura)Spain